Faculty in the Section of Atherosclerosis and Vascular Medicine conduct basic science, clinical, and translational research on the mechanisms, diagnosis, and prevention of cardiovascular disease and other cardiometabolic disorders, and on the identification and treatment of cardiovascular risk factors including dyslipidemia, hypertension, and thrombosis.
Research facilities include both core and individual faculty labs, and research projects range from investigator-initiated experiments to the large epidemiological Atherosclerosis Risk in Communities (ARIC) Study to multisite clinical trials of preventive therapies.
Basic Science Research
Basic scientists in the section investigate the pathophysiology and underlying mechanisms of dyslipidemias, arrhythmias, endothelial dysfunction, thrombosis, obesity, and other components of cardiometabolic disease. In faculty labs, researchers use biochemistry, cell and molecular biology, electrophysiology, genetics, molecular biophysics, and transgenic animal models to provide insights into the disease process that may eventually lead to improvements in human healthcare practice and preventive strategies
See a list of our basic science research by investigator.
Clinical Research
Section faculty members design and perform clinical research projects in centralized labs and centers as well as in the Lipid Metabolism and Atherosclerosis Clinic. Ongoing studies include NIH-supported projects and industry-sponsored research.
See a list of our clinical research by investigator.
